The omentum, a niche for premetastatic ovarian cancer
- PMID: 32103261
- PMCID: PMC7144536
- DOI: 10.1084/jem.20192312
The omentum, a niche for premetastatic ovarian cancer
Abstract
The work by Etzerodt et al. in this issue of JEM (https://doi.org/10.1084/jem.20191869) identifies a distinct omentum-resident macrophage population of embryonic origin and demonstrates that these cells provide a niche for ovarian cancer metastasis and cancer stemness. This research opens up for many questions and therapeutic prospects.
© 2020 Ma.
Figures
Comment on
-
Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer.J Exp Med. 2020 Apr 6;217(4):e20191869. doi: 10.1084/jem.20191869. J Exp Med. 2020. PMID: 31951251 Free PMC article.
Similar articles
-
Neutrophil: A mobile fertilizer.J Exp Med. 2019 Jan 7;216(1):4-6. doi: 10.1084/jem.20182059. Epub 2018 Dec 19. J Exp Med. 2019. PMID: 30567720 Free PMC article.
-
Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer.J Exp Med. 2020 Apr 6;217(4):e20191869. doi: 10.1084/jem.20191869. J Exp Med. 2020. PMID: 31951251 Free PMC article.
-
Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1.Commun Biol. 2020 Sep 22;3(1):524. doi: 10.1038/s42003-020-01246-z. Commun Biol. 2020. PMID: 32963283 Free PMC article.
-
Omentum provides a special cell microenvironment for ovarian cancer.Cancer Rep (Hoboken). 2023 Oct;6(10):e1858. doi: 10.1002/cnr2.1858. Epub 2023 Aug 21. Cancer Rep (Hoboken). 2023. PMID: 37605299 Free PMC article. Review.
-
Is routine omentectomy of grossly normal omentum helpful in surgery for ovarian cancer? A look at the tumor microenvironment and its clinical implications.Gynecol Oncol. 2021 Apr;161(1):78-82. doi: 10.1016/j.ygyno.2020.12.033. Epub 2021 Jan 9. Gynecol Oncol. 2021. PMID: 33436287 Review.
Cited by
-
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis.Cancers (Basel). 2021 Sep 24;13(19):4795. doi: 10.3390/cancers13194795. Cancers (Basel). 2021. PMID: 34638280 Free PMC article.
-
A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression.Med Oncol. 2022 May 15;39(5):71. doi: 10.1007/s12032-022-01665-4. Med Oncol. 2022. PMID: 35568777 Free PMC article.
-
Exosomes: A potential tool for immunotherapy of ovarian cancer.Front Immunol. 2023 Jan 18;13:1089410. doi: 10.3389/fimmu.2022.1089410. eCollection 2022. Front Immunol. 2023. PMID: 36741380 Free PMC article. Review.
-
Basal cell adhesion molecule promotes metastasis-associated processes in ovarian cancer.Clin Transl Med. 2023 Jan;13(1):e1176. doi: 10.1002/ctm2.1176. Clin Transl Med. 2023. PMID: 36647260 Free PMC article.
-
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis.Cell Rep Med. 2022 Dec 20;3(12):100856. doi: 10.1016/j.xcrm.2022.100856. Cell Rep Med. 2022. PMID: 36543113 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical